This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|July 2, 2009
- Pharmaceutical Technology-07-02-2009
- Volume 33
- Issue 7
Pharmaceutical Technology, July 2009 Issue (PDF)
Down the Track: Different Speeds with Multiple APIs
Advertisement
Articles in this issue
about 17 years ago
Using NIR to Move Bioprocessing into a PAT Frameworkabout 17 years ago
East Meets West in Contract Biologics Manufacturingabout 17 years ago
Down the Track: Different Speeds with Multiple APIsabout 17 years ago
Integration of PAT in Biopharmaceutical Research: A Case Studyabout 17 years ago
A Tale of Two Techniquesabout 17 years ago
Manufacturers Face New Risk-Management Requirementsabout 17 years ago
Can Industry Learn to Share?about 17 years ago
Next-Generation Facilities for Monoclonal Antibody Productionabout 17 years ago
The Biopharmaceutical Manufacturing Surveyabout 17 years ago
In the Spotlight July 2009Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement